HB 473: Controlled substances; Schedule I; provide certain provisions
Última acción: 1 de mayo de 2025 · Effective Date 2025-05-01
House Bill 473 updates Georgia's list of controlled substances and dangerous drugs, adding newly identified synthetic drugs to Schedule I and adding many recently approved prescription medications to the state's dangerous drugs list.
Los resúmenes de abajo son traducciones de resúmenes en inglés escritos por un modelo de IA (claude-sonnet-5) a partir del texto del proyecto de ley; no forman parte de él. El proyecto de ley está en inglés. Cite el texto, no el resumen. El texto almacenado es la versión Enrolled, la más reciente que tiene LegiScan.
El resumen en español de este proyecto de ley se está preparando. Mientras tanto se muestra el resumen en inglés.
En lenguaje claro
Georgia law keeps a running list of controlled substances (drugs regulated because of abuse potential) and a separate list of dangerous drugs (medications that legally require a prescription). Both lists need periodic updates as new substances appear on the illegal drug market or new medicines get approved. This bill amends Georgia's controlled substances law (O.C.G.A. § 16-13-25) to correct a chemical name, reclassify one substance from a placeholder listing to a named substance, and add two new synthetic substances, including a chemical group linked to synthetic drugs. It also amends the dangerous drug law (O.C.G.A. § 16-13-71) by adding roughly 60 newly named prescription drugs and biologics, plus one allergen powder product, to the list of medications requiring a prescription. The bill does not change penalties or enforcement procedures; it only updates the substances covered by existing rules. It would take effect immediately once signed by the Governor, or automatically become law without a signature.
Qué hace el proyecto de ley
- Corrects the chemical name of a Schedule I substance from a general 'methyl' compound to the specific compound '2-methyl-AP-237.'
- Replaces a placeholder ('Reserved') Schedule I listing with the named substance Acetylpsilocin, a hallucinogenic compound.
- Adds Ethylphenidate and a tetrahydrothiophene chemical group as newly regulated Schedule I controlled substances.
- Adds roughly 60 newly named prescription drugs, biologics, and vaccines (such as Resmetirom, Ensifentrine, and a smallpox/mpox vaccine) to Georgia's dangerous drug list.
- Adds a peanut allergen powder product to the dangerous drug list, meaning it would require a prescription under Georgia law.
A quién afecta
Pharmacists, physicians, and drug manufacturers who must classify and dispense the newly listed medications correctly; law enforcement and prosecutors handling cases involving the newly named Schedule I substances; and patients who rely on the newly listed prescription drugs and vaccines.
Por qué importa
Keeping these lists current means new synthetic drugs can be prosecuted as controlled substances and new medications are properly classified as requiring a prescription, affecting how pharmacies dispense them and how law enforcement handles emerging street drugs.
Disposiciones clave
- Section 1 corrects a Schedule I chemical name in O.C.G.A. § 16-13-25 from 'Methyl' to '2-methyl-AP-237.'
- Section 2 replaces a 'Reserved' placeholder with the named substance Acetylpsilocin under Schedule I.
- Section 3 adds Ethylphenidate as a new Schedule I substance.
- Section 4 adds the tetrahydrothiophene group to the chemical classes covered under Schedule I.
- Section 5 adds about 60 newly approved prescription drugs and biologic products to the dangerous drug list in O.C.G.A. § 16-13-71.
- Section 6 adds a peanut allergen powder product to the dangerous drug list.
- Section 7 makes the Act effective immediately upon the Governor's signature or upon becoming law without signature.
Del proyecto de ley
“(CC) Acetylpsilocin (4-acetoxy-N,N-dimethyltryptamine, 4-AcO-DMT);”
“(III) Tetrahydrothiophene group;”
Cronología del estado
- Effective Date 2025-05-01
- Act 45
- House Date Signed by Governor (Cámara de Representantes)
- House Sent to Governor (Cámara de Representantes)
- Senate Passed/Adopted (Senado)
- Senate Third Read (Senado)
- Senate Read Second Time (Senado)
- Senate Committee Favorably Reported (Senado)
Mostrar el historial completo (15 acciones)
- Senate Read and Referred (Senado)
- House Passed/Adopted (Cámara de Representantes)
- House Third Readers (Cámara de Representantes)
- House Committee Favorably Reported (Cámara de Representantes)
- House Second Readers (Cámara de Representantes)
- House First Readers (Cámara de Representantes)
- House Hopper (Cámara de Representantes)
Patrocinadores
- Ron Stephens (R, HD-164)
- Lee Hawkins (R, HD-027)
- Mark Newton (R, HD-127)
- Ben Watson (R, SD-001)
Votaciones
- Votación: Cámara de Representantes3 de marzo de 2025
170 a favor, 0 en contra (4 sin votar, 6 ausentes)
- Votación: Senado27 de marzo de 2025
53 a favor, 0 en contra (1 sin votar, 2 ausentes)
Temas
- controlled substances
- drug scheduling
- prescription drug regulation
- Georgia drug law